X
Dr.Dean Tsao
Chairman & Chief Executive Officer
Dr. Tsao has over 30 years of extensive experience in the IVD industry. He is an accomplished scientist and a successful serial entrepreneur with an excellent track record of launching and leading new companies to grow into successful businesses. The companies he has established have developed thousands of products that are currently being used in the diagnosis and research of cancer, HIV, Down syndrome, and numerous other medical conditions. He received his Ph.D. of Biochemistry from Colorado State University.
X
Dr.Chin-Shiou Huang
VP & Chief Technology Officer
Dr. Huang has over 20 years of research experience in areas related to biotechnology. In 1999, he invented an artificial antibody fabrication technology and co-founded Aspira Biosystems. Dr. Huang led an advanced research team that applied the a-state-of-the-art artificial antibody technology to protein capture mechanism in many platforms, such as sequence-specific protein capture beads and protein capture array chips. Aspira was funded by Alloy Ventures and later acquired by Nanomune Inc. He received his Ph.D. in Biochemistry and Molecular Biology from Cornell University.
X
Ms. Lipi Yeh
Chief Financial Officer
Ms. Yeh has over 28 years of experience in finance and operations management working for several large multi-national companies. Prior to joining PlexBio, Co. Ltd. she was Chief Operating Officer at Precious Mountain Ent. Corp., one of the largest manufacturers of PVC gloves. Earlier, Ms. Yeh was CFO at Howteh Technology Co., Ltd. where she also held senior executive positions leading sales and finance teams within the company. She is a graduate of Providence University (Taiwan).
X
Dr. Stuart M. Palmer
Chief Operating Officer
Dr. Palmer has over 30 years of scientific and executive management experience in biotechnology operations and in vitro diagnostic assay development. Prior to joining PlexBio Co., Ltd., he was the Vice President of Technical Operations for Roche Molecular System, Inc., a subsidiary of Hoffmann-La Roche, Inc. and held various positions of increasing responsibility at Abbott Diagnostics, a division of Abbott Laboratories. Dr. Palmer is also the founder and Principal Consultant of BioConsulting International, LLC. Dr. Palmer received his Ph.D. in Microbiology, a Joint Degree from Rutgers University and the University of Medicine and Dentistry of New Jersey.
X
Dr. Peter Friebe
Senior Director, Application & Customer Support - (US/EU)
Dr. Friebe has over 10 years of research experience and brings extensive knowledge and experience in the fields of molecular biology, infectious diseases and molecular diagnostic assay development. Prior to joining PlexBio Co., Ltd., he was the Vice President of Research and Development for Zytogenex USA, Inc. in North America where he successfully established nanotechnology-based signal amplification methods. Dr. Friebe also worked for Genemed Biotechnologies, Inc. as a Scientist developing IVD reagents. Dr. Friebe received his Ph.D. in Biology from the Johannes Gutenberg University Mainz, Germany.
X
Mr. Eddy Lu
Director, Instrumentation Department
Mr. Lu has nearly 15 years of experience in software development and system integration. Prior to joining PlexBio, he was the director of the Information Division at Zhengzheng Precision, specialized in the introduction of product lifecycle management systems, PLM integration of R&D related data management, process operation management (BPM) and ERP system related integration. He graduated from the Central University with the degree in civil engineering.
X
Mr. Clement Huang
Director, International Sales & Marketing - (APAC/ME)
Mr. Huang has nearly 15 years of sales experience in medical device industry with a sound experience in ODM/OEM and branding business. Prior to joining PlexBio, he was the Sales Director for Americas and Asia Pacific Region at Rossmax International Ltd., a renowned home health care brand, where he successfully supervised and delivered on the sales goals. Mr. Huang has a degree in French from Fu-Jen University, and graduated from International Trade Institute (ITI), Spanish Group, a 2-year training program organized by TAITRA.
X
Mr. Aidan Coe
Director, International Sales & Marketing (EU/NA)
Mr. Coe has over 10 years of sales experience in various technology and consumer sectors. Prior to joining PlexBio Co., Ltd. he was a lead sales manager for Techtronic Industries in North America where he consistently delivered on aggressive growth goals while taking on several roles of increasing responsibility. Mr. Coe is a Business Administration and International Marketing graduate of the University of California (Riverside).

About PlexBio

Since 2010 PlexBio has been designing, developing, and manufacturing our proprietary cutting-edge multiplexing platform and assays, to enable broad genetic research and more specifically, clinical cancer diagnostics.

Our Mission

Our mission at PlexBio is to address the issue of rising healthcare costs and increasing number of available diagnostic tests, by creating simple, streamlines, and cost-effective laboratory solutions that will meet the demands of our growing world.

Who We Are

PlexBio's team of scientists and researchers worked together to develop PlexBio's proprietary MicroDisc technology and advanced instrumentation. Everyday we continue to develop novel uses for our technology, driving toward our mission.

Our Team

Dr.Dean Tsao

Chairman & Chief Executive Officer

Dr.Chin-Shiou Huang

VP & Chief Technology Officer

VIEW BIO ⟶

Ms. Lipi Yeh

Chief Financial Officer

Mr. Clement  Huang

Director, International Sales & Marketing - (APAC/ME)

VIEW BIO ⟶

Mr. Eddy Lu

Director, Instrumentation Department

VIEW BIO ⟶

Our Board

Dean Tsao
Rimiru Hayashida
Yasuhiro Ohashi
Stuart M. Palmer
I-Chun Lai
Ter-Fung Tsao
Guoliang Yu
Dean Tsao

Dean Tsao

Chairman & Chief Executive Officer

Dr. Tsao has over 30 years of extensive experience in the IVD industry. He is an accomplished scientist and a successful serial entrepreneur with an excellent track record of launching and leading new companies to grow into successful businesses. The companies he has established have developed thousands of products that are currently being used in the diagnosis and research of cancer, HIV, Down syndrome, and numerous other medical conditions. He received his Ph.D. of Biochemistry from Colorado State University.
Rimiru Hayashida

Denka Company Limited – Rep: Rimiru Hayashida

Director

Mr. Hayashida graduated from School of Commerce of Waseda University, and is the Executive Officer at Denka Company Limited.
Yasuhiro Ohashi

Denka Company Limited – Rep: Yasuhiro Ohashi

Director

Mr. Ohashi Graduated from Applied Chemistry of Keio University, and is the General Manager of Advanced Diagnostics Business Development Department, Life Innovation of Denka Company Limited.
Stuart M. Palmer

DPT Biofund LLC - Rep: Stuart M. Palmer

Director

Dr. Palmer has over 30 years of scientific and executive management experience in biotechnology operations and in vitro diagnostic assay development. Dr. Palmer has received his Ph.D. in Microbiology, a Joint Degree from Rutgers University and the University of Medicine and Dentistry of New Jersey. He was the Vice President of Technical Operations for Roche Molecular System, Inc., a subsidiary of Hoffmann-La Roche, Inc. Currently, he is the Founder and Principal Consultant of BioConsulting International, LLC.
I-Chun Lai

I-Chun Lai

Independent Director

Prior to retirement, Professor Lai was a Professor and Dean of the College of Business and Management at Overseas Chinese University. She also has taught in the Department of Accounting Information at the National Taichung University of Science and Technology. Professor Lai has received her M.A. degree in Accounting & Public Finance from Feng Chia University, and is a well-certified public accountant.
Ter-Fung Tsao

Ter-Fung Tsao

Independent Director

Dr. Tsao is currently the Chairman of Standard Food Corporation in Taiwan. Dr. Tsao has received his Ph.D. degrees in Food Science and Human Nutrition and Sanitary Engineering from Colorado State University.
Guoliang Yu

Guoliang Yu

Independent Director

Dr. Yu is the Chairman of Qyuns Therapeutics and the co-founder of Epitomics Inc.. Dr. Yu became one of the first Senior Scientists at Human Genome Sciences Inc., identifying human genes for drug discovery, he also served as Senior Vice President of R&D at Mendel Biotechnology Inc. Dr. Yu received his Ph.D. in Molecular Biology from the University of California, Berkeley.

Our Partners

Corporate History

PlexBio Timeline

 PlexBio Co., Ltd was established with a registered capital of $52,600,000 NT in 2009.

view more

Certification

Button